78: 1-33, 1998.-Sexual dimorphism in humans has been the subject of wonder for centuries. In 355 BC, Aristotle postulated that sexual dimorphism arose from differences in the heat of semen at the time of copulation. In his scheme, hot semen generated males, whereas cold semen made females (Jacquart, D., and C. Thomasset. Sexuality and Medicine in the Middle Ages, 1988). In medieval times, there was great controversy about the existence of a female pope, who may have in fact had an intersex phenotype (New, M. I., and E. S. Kitzinger. J. Clin. Endocrinol. Metab. 76: 3-13, 1993.) . Recent years have seen a resurgence of interest in mechanisms controlling sexual differentiation in mammals. Sex differentiation relies on establishment of chromosomal sex at fertilization, followed by the differentiation of gonads, and ultimately the establishment of phenotypic sex in its final form at puberty. Each event in sex determination depends on the preceding event, and normally, chromosomal, gonadal, and somatic sex all agree. There are, however, instances where chromosomal, gonadal, or somatic sex do not agree, and sexual differentiation is ambiguous, with male and female characteristics combined in a single individual. In humans, wellcharacterized patients are 46, XY women who have the syndrome of pure gonadal dysgenesis, and a subset of true hermaphrodites are phenotypic men with a 46, XX karyotype. Analysis of such individuals has permitted identification of some of the molecules involved in sex determination, including SRY (sex-determining region Y gene), which is a Y chromosomal gene fulfilling the genetic and conceptual requirements of a testis-determining factor. The purpose of this review is to summarize the molecular basis for syndromes of sexual ambiguity seen in human patients and to identify areas where further research is needed. Understanding how sex-specific gene activity is orchestrated may provide insight into the molecular basis of other cell fate decisions during development which, in turn, may lead to an understanding of aberrant cell fate decisions made in patients with birth defects and during neoplastic change. consists of repeated DNA (70) , and sex determination pro-Y DNA was lost by deletion in XY phenotypic females, Page et al. (318) were able to define a critical region ceeds normally when the distal long arm of the human Y is deleted (262) , showing that this region harbors no for testis determination that was just proximal to the pseudoautosomal X-Y pairing region on the short arm of information necessary for sex determination.
The third type of Y genetic material is unique Y chro-the Y, and focused their attention on a 140-kb segment that was present in one XX male (LGL203) and absent in mosomal DNA that does not undergo recombination with the X chromosome. It is in this unique Y DNA that the another XY female patient (WHT1013). A highly conserved gene in this portion of the Y (called zinc-finger Y, TDF is located. Unique Y region DNA cannot be analyzed by traditional genetic methods that depend on recombina-or ZFY) encodes a zinc-finger containing DNA-binding tion frequency to determine the distance between loci; protein that was initially thought to be the TDF (318). instead, the unique Y region can be analyzed by correlat-Evidence consistent with the assignment of ZFY as TDF ing presence of Y-specific DNA markers to Y chromo-included finding ZFY-related sequences on Y chromosomes with cytogenetic abnormalities. Maps of the Y chro-somes of all mammals tested and finding that a ZFYmosome based on DNA hybridization (147, 449) and maps related gene, Zfy-1, was present in the mouse sex debased on deletions occurring in human patients (427) termining region, a region termed Sxr. However, addiwere developed to assist not only in the search for the tional study revealed that ZFY could not be the TDF: a testis-determining gene, but also to facilitate study of Y close homolog of ZFY was found on the X chromosome genes involved in spermatogenesis (11, 16, 260, 458, 460) of eutherian mammals (361). Also, ZFY expression was and to facilitate understanding of chromosome structure found to be in germ cells, which are not required for and function. testicular differentiation, and testes differentiation was unaffected in W In nonrodent species, SRY exhibits much less tissue in the steroid hormone biosynthetic and signal transduction pathway are discussed in a section VIIIF. XY sterile specificity. All fetal human tissues examined expressed SRY, and in adult males, heart, liver, kidney, and testis females with bilateral streak gonads and sexual infantilism are said to have the pure gonadal dysgenesis synshowed SRY expression by RT-PCR analysis (63) . SRY is also expressed in HepG2 and NTERA-2 cl.D1 cell lines, drome, which is distinguished from the more common syndrome of mixed gonadal dysgenesis where mosaicism derived from adult tissues that express SRY (63) . The significance of widespread SRY expression is unclear. In-for 45, XO/46, XY, commonly leads to a streak gonad on one side and a testis on the other (283) . deed, in the tammar wallabee, Sry expression begins at the time the gonadal primordium is present, 4 days before In pure gonadal dysgenesis, both gonads are frequently streaks, and the height of patients is normal, in an increase in cytoplasmic-to-nuclear ratio heralds the onset of Sertoli cell differentiation (173) . The long time contrast to the 45, XO Turner syndrome where patients have short stature, webbed neck, cardiac defects, and delay between expression of SRY and differentiation of Sertoli cells suggests the presence of auxiliary autosomal dorsal pedal edema. The short stature of Turner patients is likely due to a Y long-arm gene mapped between Y or Y-linked factors in marsupials necessary to cooperate with SRY to regulate gonadal sex. Like human SRY, wal-intervals 4B and 5G that influences height (355); this gene may or may not be identical to a Y long-arm gene that labee Sry is expressed in many fetal and several adult tissues including brain; these results make possible a plays a role in tooth size (5a). In addition, ¢30% of pure gonadal dysgenesis patients develop gonadoblastoma widespread role for Sry in development of mammals. Certain Old World rodents have multiple copies of the Sry (420), a rare neoplasm containing aggregates of germ cells intermixed with a stromal component resembling immagene (298) ; it is unknown whether all these copies are transcribed or if some have been recruited for additional ture Sertoli and granulosa cells. Because 45, XO Turner syndrome patients who also have dysgenetic gonads never roles in development. Two rat Sry transcripts of distinct size and quantity are present in urogenital ridge cell lines develop gonadoblastoma, it has long been suspected that a Y-linked locus is responsible for gonadoblastoma, and (Haqq et al., unpublished data).
SRY cannot be the only genetic switch molecule in-the critical genetic region has now been mapped (404) . Mutation of SRY is the first molecular explanation volved in mammalian sex development; rather, a cascade of molecules seems to be operating. For example, the for the syndrome of 46, XY pure gonadal dysgenesis. As of March 1995, nearly 20 mutations in human SRY have wood lemming has three sex chromosomes, an X, a Y, and a modified X*, which functions to suppress the action been described (see Fig. 2 for an overview of 46 XY female patient mutations and mutations involved in SRY DNA of the Y (127). Even more striking, Sry is absent from the voles Ellobius lutescens and Ellobius tancrei, which have binding-F67A and I68F; Refs. 27, 36, 176, 177, 182, 209, 274, 295, 337, 385, 424, 425) . Most of these mutations lie no Y chromosome (222) . In these species, the X remains unpaired in male meiosis, making their mechanism of sex within the region of homology to the conserved HMG box DNA binding domain, with the exception of one COOHdetermination an interesting topic for future investigation.
Furthermore, in marsupial mammals where the Y terminal mutation resulting in premature termination of the SRY open reading frame 41 amino acids short of the chromosome determines gonadal sex, many sexual determinants such as scrotum versus pouch formation occur full-length protein (385) . The recent finding that the COOH-termimal region binds a novel PDZ domain-conbefore differentiation of the gonads (307) , under control of a separate system based on the ratio of X chromosomes taining protein, SRY-interacting protein-1 (SIP-1) (336) , adds to the significance of this mutation. The fact that to autosomes (366) . Further investigations in these model systems promise to lead to identification of additional sex-only 15% of 46, XY pure gonadal dysgenesis patients have an SRY mutation suggests that SRY is only one of several determining molecules, and it will be interesting to see how Y-determining and X to autosome-determining sys-genetic loci whose mutation can lead to an identical phenotype. The etiology of the remaining patients must be tems can coexist.
due to mutations in genes that affect the expression of SRY itself or that play independent roles in a cascade of where 46, XX individuals display a masculinized pheno-in the absence of the Y. For example, XX gonadal primordia transplanted under the kidney capsule of adult male type. The bulk of such patients now come to medical attention in infancy, suffering the effects of steroid biosyn-hosts develop into ovotestes (391) . In these experiments, XX Sertoli cell development is delayed by 7 days relative thetic defects leading to congenital adrenal hyperplasia, which is discussed in section VIIID. This is distinguished to XY Sertoli cells. Sertoli development requires contact with the host tissue (390) , and Mü llerian inhibiting subfrom true hermaphrodites, 90% of whom are 46, XX with a mixture of ovarian and testicular tissue either on different stance (MIS) is produced concomitant with loss of germ cells in the resulting ovotestes (389) . sides of the body or within a single gonad, or rarely bilateral testes (81, 113, 163, 251) . True hermaphrodites come
IV. MUTATIONS IN
The embryological origin of Sertoli and Leydig cell precursors is not well understood. In light and electron to attention during infancy due to ambiguous genitalia (97) , or later in life due to infertility. A high incidence microscopic studies, both contributions from coelomic epithelium and mesonephros are implicated (357). In vivo, of true hermaphroditism occurs in African Bantu tribal nations (416) . Gonadoblastoma is not a frequent finding many connections of the convoluted mesonephric tubules continuous with the gonadal primordium are seen in both (2.6%; Ref. 416) in true hermaphrodites, even those who have inherited Y DNA, presumably because the gonad-male and female mouse embryos at the earliest time studied, day 11.5 post coitum, and are extinguished by day oblastoma susceptibility region is not always coinherited with the SRY locus (163). Likewise, reports of rare pater-12.5 (225) . Mesonephros-gonad connections could contribute cells that would give rise to the Sertoli cell lineage; nity may correlate with translocation of sufficient Y material to include spermatogenesis loci along with the testis-however, RT-PCR for the linear urogenital ridge SRY transcript in microdissected day 11.5 post coitum mesonephri determining locus.
SRY translocation to the X chromosome or an au-and gonads found expression only in the gonad proper, so if pre-Sertoli cells come from the mesonephros, they tosome accounts for Ç30% of true hermaphrodites (163, 251). Genotype-phenotype correlation shows that individ-are not yet competent to express Sry (211) . Experiments in organ culture using testes older than 11.5 days post uals with SRY translocations have normal male external genitalia, whereas those without SRY present genital am-coitum show cell recruitment from the mesonephros contributing to the myoid, endothelial and possible Leydig cell biguity (113, 306) . Although mosaicism with a Y-bearing cell line could explain remaining cases of true hermaphro-populations (225); in fact, placement of a semipermeable membrane between mesonephros and gonad led to the ditism, there is a dearth of supporting evidence, and it is likely that the bulk of cases arise from mutations of failure of further gonadal development (40, 285). Another source of mesenchyme, the hindlimb bud, is able to substiautosomal loci important to sex differentiation.
tute for mesonephros in organ culture experiments, but the sex of the donor limb tissue had a marked effect VI. BIOCHEMICAL ACTIVITIES OF SRY: HOW on subsequent testosterone output by the putative Leydig DOES SRY DETERMINE SEX? cells (292).
In our work, we have made immortalized rat gonadal SRY must act to control the process of gonad forma-cells using retrovirus to introduce the v-myc oncogene at tion. Normally, differentiation of the gonadal primordium day 14. express urogenital ridge markers (Fig. 3, A and B) . Each be a reasonable way to discover markers specific to particular early cell types present in the gonad. cell type has a distinct morphology in phase-contrast light microscopy. In experiments where two cell types were SRY biochemistry provides some inroads to begin addressing the question of how this transcription factor mixed together, we were intrigued to find that CH-17 cells have the ability to organize other cell types into aggregates operates to activate the events necessary to form the gonad. The 80-amino acid HMG box DNA binding domain is that bear an at least superficial resemblance to early testicular cords (Fig. 3C) . Much work lies ahead to develop highly diverse, ranging in particular HMG box proteins from 72 to 83 amino acids in length and containing three molecular markers capable of distinguishing the various early gonadal cell types. Comparing patterns of gene ex-a-helical regions. SRY's HMG box is 77 amino acids in length, of average length compared with other HMG pression in the urogenital cell lines described here may boxes. In addition, there are no strictly conserved amino in deletion of the 41 most COOH-terminal amino acids has been described (385; see Fig. 2 ), and more recently, acid sequences between all members of the superfamily: only three amino acids are conserved in ú80% of HMG this region was found to bind a novel protein termed SIP-1 (336) . This PDZ domain containing protein may favor boxes: P at position 8, W at position 45, and K at position 53 (243).
protein-protein interactions in a higher order transcription complex. Some members of each of the HMG groups are present in large quantities, bind DNA with little sequence specificity, and bind novel DNA structures including four-way A. SOX Genes and Functions junctions that are thought to be intermediates involved in DNA recombination. In contrast, the group of HMG-1/-2 box proteins to which SRY belongs possesses both se-SOX genes are present in several species as closely related groups of molecules, as in the Drosophila melanoquence-specific and DNA structure-specific binding. Because mutations in SRY found in cases of XY sex reversal gaster HMG-D cluster, the mouse Sox 1 cluster, and the reptile Sox 12 cluster. Because whole families of HMG are located in the HMG DNA binding domain, sequencespecific DNA binding is thought to play a critical role in box proteins are present in single species like Drosophila and close homologs are not present in any other animal its sex-determining function. A similar role for structurespecific DNA recognition of four-way junction elements group (243), SOX genes may have rapidly adapted during evolution to subserve species-specific roles. Very little is by SRY is unlikely, since mutations that cause sex reversal do not affect the ability of SRY to interact with four-way known about the putative species-specific or tissue-specific function of the majority of the SOX genes. junction DNA (328). SRY is closely related to a family of HMG box proteins termed the SOX (Sry bOX) family, and Expression patterns for several Sox genes have been published within the last years: Sox 1 is expressed in because many SOX genes can bind the same consensus DNA target sites that SRY binds, and many are coex-developing brain and testicular somatic cells (66); Sox 2 is expressed in developing brain, gut endoderm, and pressed in the same tissues as SRY, understanding the mechanism of SRY action must take into account the pres-testicular germ cells (66, 410); and Sox 3 is expressed in developing brain, spinal cord, adrenals, liver, thymus, ence of these proteins.
Homeodomain proteins, long thought to function spleen, pancreas, and testicular somatic cells (66, 410). Because Sox 3 maps to a part of the X chromosome associsolely by binding to DNA, have been shown to bind RNA, exerting control of translation to establish a molecular ated with mental retardation, Sox 3 is a candidate gene for X-linked mental retardation syndromes (383) . Sox 4 gradient during early Drosophila development (104, 347) . These observations provide a precedent for families of is implicated as a transcription activator in lymphocytes containing a transcription activation domain that can proteins operating to control both transcription and translation. It is intriguing that one member of the HMG protein function when fused to the DNA binding domain of GAL4 in yeast (112, 414); Sox 5 is expressed in postmeiotic germ family, HMG2, can interact with the POU domain of transcription factors Oct1 and Oct2 via its HMG domain (464), cells (83) ; Sox 6 is expressed in developing brain and adult testis (71) ; Sox 11 is expressed in mesoderm and causing a marked increase in the DNA binding activity of the Oct proteins. The inability of the SRY HMG domain neuroepithelium, with highest levels concomitant with postmitotic neural differentiation (410); Sox 18 is exto interact with Oct2 in parallel experiments (464) suggests that this type of protein-protein interaction is spe-pressed in adult heart, lung, and skeletal muscle (188) ; and zebrafish Sox 19 is expressed in late gastrulation stage cific, and it is tempting to speculate that the SRY HMG domain may itself be a protein-protein interaction domain. embryos (428) .
Knowing that campomelic dysplasia was associated The structures of SRY coding regions in various species have been evolving at a rapid rate (243, 406, 445), with primary gonadal dysgenesis (403a), and finding the sequence of the SRY-related gene SOX 9 (125) at the and little homology is present in these molecules outside of the DNA binding HMG box region. The lack of homol-breakpoint of a patient with campomelic dysplasia, led to the realization that mutations in SOX 9 were responsible ogy outside of the HMG box led to the proposal that the only important part of the SRY molecule was its HMG for both syndromes (401, 430). SOX 9 is expressed at the right time in the developing urogenital ridge to cooperate DNA binding domain. This hypothesis has been reconsidered since the COOH-terminal non-HMG region of the SRY with SRY itself in sex determination. Ontongeny analysis of SOX 9 indicates that it is expressed at higher levels in molecule is changing faster than can be explained by accumulation of neutral mutations having no effect on SRY the somatic cells of the male gonad immediately after SRY expression (291) . Because these two gene products are function. Instead, it seems that changes in the SRY COOH terminal must give SRY a species-specific advantage (406, coexpressed in the soma of the gonad in a male specific pattern, analysis of how the two interact may shed light 445). In support of there being a role for non-HMG box regions of SRY, a mutation in an XY female that results on the mechanism of Sry action and sex determination. 
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Alternately, it is possible that SOX 9 may be expressed in ficity of this interaction was apparent, since Sox 5 and Oct-2 were unable to substitute in cotransfection assays. a cell type that interacts with the Sertoli cells expressing SRY, to specify competence to respond to a Sertoli cell These assays suggest that SRY can only activate in a specific context of combined binding sites. SRY-induced signal (proposed in Ref. 47 ). Because SOX 9 plays an important role in the development of mesodermPosttranslational modification of SRY might modify the activity of SOX proteins. TCF-1a/LEF-1 can activate derived skeletal elements, the SOX 9 positive cell type might be the mesonephric cells that migrate into the go-transcription through a single copy of its response element in nonlymphoblastoid cell lines, whereas it only menad as seminiferous tubule myoid architecture is defined (40) (Fig. 4) . We speculate that these regions of conservation define protein-nucleic acid or pro-factors. The resulting constitutive gene activation can be modulated by the adenomatous polyposis coli (APC) tutein-protein interaction domains, and it will be interesting to see if they specify homotypic or heterotypic interac-mor suppressor gene in APC-deficient colon carcinoma cells (293) or melanoma cells (352) . tions.
Researchers in the SRY field can gain insight in studying SOX genes that bind to identical or very closely related B. Factors Involved in MIS Regulation binding sites in the same cell type by considering investigations of HMG box proteins in lymphocytes. For example,
The biology of the MIS is reviewed in detail in section LEF-1 (also known as TCF-1a) and TCF-1 are two HMG VIIIA. Here, we consider the interaction of SRY and MIS, proteins present in lymphocytes that can bind the same a logical putative downstream target of Sry activity, since ATTGTT consensus. LEF-1 was first characterized as a pre-MIS transcription begins within 20 h of Sry expression in B and T lymphocyte specific DNA binding protein that mouse urogenital ridge (161) and is male specific until bound to the T-cell receptor a-chain enhancer (402, 435). MIS transcription begins after birth (reviewed in Ref. 159). Subsequent studies showed LEF-1 to help assemble a multi-We determined that the bacterially expressed HMG doprotein complex on the TCR-a enhancer (141) (142) (143) and main of human SRY could protect the human MIS proto be widely expressed in embryonic tissues (310) . TCF-1, moter in deoxyribonuclease (DNase) footprint assays identified in T cells (412) , was also subsequently shown to with a nanomolar dissociation constant (167), and we and be widely expressed during embryogenesis (310) and later others (167, 170) determined that SRY binding to human during development (461) . In addition, the LEF-1 knock-out MIS promoter nucleotides 075 to 045 was diminished by had no detectable immune system phenotype and rather nucleotide point mutations. These analyses also showed led to striking effects on tooth, hair follicle, and mammary that the MIS binding site was not as high affinity a target gland development (415) , whereas the TCF-1 knock-out led site as SRY sites identified by PCR selection starting from to a specific phenotype in maturation of CD8/ to CD4// random sequence (5-ATTGTT; Refs. 168, 172) . The weak CD8/ during T-cell maturation (418) .
nature of the SRY binding sites suggested they might be Thus studies aiming to understand SRY's action will relevant only in the context of occupancy of neighboring need to be similarly inclusive, since more than one SOX binding sites for additional transcription factors. Thus we protein can interact with its target element, and SRY pro-made cell lines from the urogenital ridge at the precise tein is present at levels orders of magnitude lower than time that differentiation of the testis was in progress other members of this family. The question of how such (168) , in the hope that such lines would contain all factors factors can achieve specificity in their actions is of major necessary to transcribe the MIS promoter. importance. It has been proposed that SRY might cooperHuman SRY does not have a transcription activation ate with other transcription factors to achieve specificity domain detectable by fusing SRY to the DNA-binding do- (254) . Some investigators have suggested that SRY may main of GAL4; in contrast, mouse Sry possesses a COOHcooperate with AP-1-type transcription factors (64) . In terminal domain that has activity in transcription activasupport of such models, Sox 2 is required to cooperate tion when fused to the DNA binding domain of GAL4 with Oct-3 at a fibroblast growth factor-4 enhancer that and transfected with a reporter containing GAL4 promoter sites (103) . In a male urogenital ridge cell line, CH-34, is active in embryonal carcinoma cell lines (457 cotransfection of an expression vector directing synthesis in our assay leads to a strong repression of MIS transcription ( Fig. 5B ). Mouse SRY (data not shown) was also of human SRY with an MIS reporter plasmid resulted in a dramatic induction of transcription (168) . This activation unable to activate the human SRY reporter in this assay.
Ongoing experiments should address the question of appeared to be specific, since no activation was seen for the Rous sarcoma virus LTR promoter or the mouse actin whether SRY and other HMG proteins known to be expressed in the urogenital ridge might exhibit synergism promoter (Fig. 5A ).
In addition, the response of the transfection system or antagonism, but specificity with the Sox gene family. to SRY is highly specific at the protein level. We find that SRY is the only HMG protein able to greatly activate the C. Mutated SRY From Sex-Reversed Patients Fails human MIS promoter reporter constructs; HMG-2 and to Activate MIS LEF-1 are incapable of upregulating in our assay when equal amounts of expression plasmid are transfected. IREMutated SRY protein I68T found in an XY sex-re-ABP gives upregulation of the reporter to levels only about one-tenth those achieved with SRY, and Sox 2 transfected versed phenotypic female had diminished DNA binding (7) or expression vector directing expression of full-length human SRY (2 mg) into urogenital ridge cell line CH-34. Human Mü llerian inhibiting substance (MIS) reporter vector was generated by cloning the fragment 0299 to /8 generated by PCR using primers CMH-106 5-ggg Agg CTTggCCgTCACTCCCAgCCTg and CMH-107 5-CggAAgCTTggg TgCTgCCAggggCTg, into Hind III site of SVO-CAT (149a). Forty hours after transfection by the calcium phosphate method, cells were harvested and assayed for CAT activity by thin-layer chromatography (232). B: comparison of fold induction of 0114 bp human MIS-luciferase reporter (2 mg) by SRY, LEF-1, Sox 2, IRE-ABP, or control empty expression vectors (1 mg). The 0114 to /8 fragment of human MIS promoter was generated by PCR using primers CMH-128 5-ggTACCgggCACTgTCCCCCAAgg and CMH-107. Resulting fragment was sequenced for confirmation and subcloned between Kpn I and Hind III sites of luciferase reporter pA3 (451) . Although SRY was a strong activator in this assay, Sox 2 was a strong repressor, whereas IRE-ABP was a weak activator and LEF-1 had no consistent effect. Luciferase data are an average of 3 independent transfections { SE. All transfections included 0.5 mg pXGH5, which directs expression of growth hormone under the control of a ubiquitously active promoter (364) . Growth hormone determinations were used as an internal standard to control for variations in transfection efficiency. finity in DNA-binding gel-shift assays (E. Ukiyama, C. activity in bandshift assays and failed to activate tranHaqq, Y. Morikawa, M. Weiss, and P. Donahoe, unpubscription of the reporter plasmid (168) . Biophysical analylished data). W98R fails to fold properly and was therefore sis of the interaction of this mutant protein I68T led to excluded from further analysis. Figure 6C presents an the identification of a hydrophobic wedge that intercalates analysis of transcriptional activation by mutant SRY probetween adjacent A-A base pairs in SRY binding sites (168, teins M64A, M64I, F67A, and I68T assayed by transient 230, 253, 441, 442; Ukiyama et al., unpublished data; Fig. cotransfection of mutant SRY molecules with MIS-lucifer-6A). An analogous mechanism of nucleic acid recognition ase reporter plasmids in urogenital ridge cell line CH-34. is used by the TATA-binding protein (228, 229) , the Hae All mutations of hydrophobic wedge positions resulted in III methyltransferase (342), and PurR (363), DNA-binding substantial loss of transcription response. Mutation of the proteins belonging to diverse gene families, suggesting isoleucine-68 to threonine results in 50-fold decreased that this mechanism is widely utilized.
DNA binding and lack of transcription response (168; Fig. Nuclear magnetic resonance structure determination 6C). Because isoleucine-68 is the position that plays an has defined the four residues M64, F67, I68, and W98 that important structural role in DNA binding by intercalation constitute the hydrophobic wedge, which is conserved in into a widened minor groove, the lack of transcription many HMG box sequences (442; Fig. 6B ), and we have seen when the mutant protein is transfected into cells now extended our analysis of defective SRY proteins to proves that DNA binding activity is necessary for SRY to include hydrophobic wedge mutants M64I, M64A, F67A, show upregulation in the assay, arguing against artifactual I68T, and W98R. Three of these mutants, M64I, I68T, and transcription due to nonspecific protein-protein interac-W98R, are clinically associated with sex reversal.
tions. Mutants M64A, F67A, and I68T are well folded after synthesis in Escherichia coli, and all show decreased afAlthough mutation of the first hydrophobic wedge Positions of amino acids whose side chains constitute hydrophobic wedge are boxed and are present within helix 1 and helix 2 of HMG structure predicted by analogy to known structures of SRY and LEF-1 (253, 441) . C: transfection analysis performed as in Fig. 5B , using expression vectors encoding mutant SRY strains indicated. Luciferase data are presented as a mean of 3 independent transfections { SE after normalization to an internal growth hormone control. All 4 mutations at hydrophobic wedge positions decreased transcription response seen in transfection assay. M64I and I68T from sexreversed patients, as well as M64A and F67A, predicted to have defective function based on SRY structure, all show decreased transcription of 0114 bp human MIS-luciferase reporter vector. Note that M64I has partial activity in assay (see text). D: transfection of a variable amount of SRY mutant I68F or wild-type expression vector (0-5 mg) with a fixed amount of 0114 bp human MIS-luciferase (2 mg). Empty expression vector pCMV was used to normalize total amount of DNA present in each assay. All points on graph are means { SE of 3 replicates, corrected for transfection efficiency using an internal growth hormone standard. SRY I68F shows a markedly enhanced ability to transactivate the 0114 bp human MIS-luciferase reporter vector. Response to SRY the transcription response, mutant protein M64I, which is associated with sex reversal clinically, had partial activity in the transfection assay. Analysis at this position Analysis of deletion constructs of the human MIS promoter showed that coexpressed SRY was able to stimagain demonstrates a tight correlation of SRY activity in the transfection assay with biochemical analysis. Previ-ulate even very small fragments of the MIS promoter as long as they contained the start site for transcription. ous investigation of the M64I mutation showed that the DNA binding activity was largely intact (õ2-fold decre-However, the quantitative amount of SRY-induced transcription was greatly reduced by each deletion. The fact ment in DNA binding affinity; Refs. 171, 334; Ukiyama et al., unpublished data), but that the angle induced upon that the smallest fragments that do not contain a binding site for SRY still upregulated suggested that the cotrans-DNA binding was greatly altered (334) . For this reason, it was proposed that a defect in DNA bending was the fection system might be biased because of SRY binding to sites within the vector itself (Morikawa et al., unpublished explanation for sex reversal with the M64I mutation. However, recent results prompt reevaluation of this hy-data). In support of this, empty reporter vector without an MIS promoter insert could be stimulated by transfecpothesis. Our group has determined that the decrement in DNA bending by the M64I mutation is only 30Њ (Ukiy-tion of large amounts of SRY. Sox 18's transactivation properties include the same activation of the empty reama et al., unpublished data). We believe the difference stems from lengths of the bacterially expressed SRY HMG porter vector, with further transcription resulting from ATTGTT sites placed upstream of a minimal promoter domains used by the two groups, the former using 77 amino acids that did not include the basic domain just (188) .
To our knowledge, all available chloramphenical ace-COOH terminal to the classic HMG box, wherease the latter used an 85-amino acid protein that did include this tyltransferase, growth hormone, and luciferase reporter vectors used for these experiments contain the simian region. The TCF-1 and LEF-1 basic region contributes to DNA binding and DNA bending (253, 341) . Experiments virus 40 (SV40) polyadenylation signal in multiple tandem copies just 5 to the promoter cloning site, and each SV40 are now under way to compare protein-induced DNA bend angles in the identical experimental assay with the polyadenylation signal contains a perfect ATTGTT match to the consensus site for binding of SRY and SOX proteins; two lengths of SRY peptides. Changes in SRY proteininduced DNA bend angle are unlikely to be responsible however, reporter vectors that use polyadenylation signals without these ATTGTT sites continued to upregulate for the diminished biological activity of the M64I molecule, unless the cotransfection assay is sensitive to in this assay (T. Clarke and P. Donahoe, unpublished data). Until the reporter vectors are purged of ATTGTT changes in bend angle of only 30Њ.
sites, it will not be clear whether SRY acts directly at SRY as suggested by DNase footprint analysis, or whether SRY induces expression of another factor which in turn acts D. Superactivator SRY Isoleucine 68 to upregulate MIS transcription. It will also be interesting Phenylalanine for future experiments to address the role of SRY in transgenic mice, since the detailed chromatin configuration of the MIS promoter in host chromosomes compared We reasoned that the hydrophobic wedge of SRY might not be optimal for intercalation into the minor with the plasmids used in transient transfection analysis might be different enough to show distinct effects on MIS groove and interruption of base stacking, since the isoleucine at position 68 is considerably less hydrophobic than transcription.
Analysis of MIS initiator region (MIS-InR), 022 to the phenylalanine present at the analogous position of other HMG proteins, including chimpanzee Sry. We pre-/8, indicates that it is capable of mediating SRY-induced transcription. Mutation of the initiator by randomization dicted that if we replaced the isoleucine-68 position of SRY in the hydrophobic wedge with phenylalanine, we of the 32-bp nucleotide sequence, or replacing the 3 16 nucleotides of the MIS-InR, which contains the transcripcould make a superactive SRY molecule. In fact, cotransfected SRY I68F yields more activation than wild-type SRY tion start site, by a heterologous sequence from phage l reduced transcription to control levels seen with empty when equal concentrations of expression vectors are cotransfected (Fig. 6D) . High concentrations of SRY I68F reporter vector. In contrast, replacing the 5 16 nucleotides of the MIS-InR with a heterologous sequence from yield a maximal activation that is at least four times higher than wild type, and 16 times higher than M64I (data not phage l had little effect. We have not been able to detect direct DNA binding of SRY to the MIS-InR region; instead, shown), suggesting a qualitative gain of function in this mutant. Future studies using this superactivating I68F mu-SRY may undergo protein-protein interactions with basal transcription factors bound to the InR in vivo, or might tant molecule may be able to shed light on the mechanism of transcription stimulation by SRY.
induce synthesis of basal transcription factors to high lev-lacZ transgenes are turned off by embryonic day 15, els resulting in a secondary increase in MIS transcription whereas the endogenous gene continues to be expressed levels.
in males at high levels until at least embryonic day 18. We previously demonstrated that SRY could bind to This suggests that all the information for initiation of MIS and protect sites in the rat aromatase P-450 promoter expression is contained in a very compact minimal pro-(167). Although aromatase is important to female sexual moter region, but that additional factors needed for maindifferentiation, aromatase transcription is seen in mouse tenance of MIS expression interact with sites upstream fetal ovaries and testes without sex specificity (245); on of or within the SAP62 gene, or within MIS introns, exons, the other hand, no aromatase activity is detected in rat or 3-sequence. ovaries during fetal life (440) and expression of aromatase A MIS promoter element termed MIS-RE-1 (368), or in the brain appears to be highly sex specific during fetal M2 (human MIS nucleotides 0114 to 093 bp; Refs. 159, life (193) . Although human SRY upregulated a 0534 to 169), matches the consensus sequence for an SF-1 binding /100 bp rat aromatase-chloramphenicol acetyltransferase site 5-CCAAGGTCG. SF-1 rendered constitutively active promoter containing the SRY footprinted region (Fig. 5A) , by deletion of its hormone binding domain can activate and cannot regulate a 0227 to /100 bp aromatase-luciferthe MIS promoter in Sertoli cells (368) ; it was proposed ase promoter lacking this region (Haqq et al., unpublished that a tissue-specific SF-1 ligand is present in Sertoli cells, data), further work is required to see if precise mutation since SF-1 responses were stronger in Sertoli cells than of the SRY footprinted region is the site of promoter reguin extragonadal HeLa cells. Intact SF-1 in a male urogenilation. Control of aromatase activity at the protein level tal ridge cell line transcriptionally repressed the MIS prois also possible, since it has been known for many years moter through this site (168) . that MIS can downregulate aromatase enzymatic activity
Although the above results suggest that SF-1 may play (423) . Contributions of transcription, translation, and staa role in MIS transcription, SF-1 is present in the ovaries bility of mRNA and protein to this phenomena have not from embryonic days 13.5 to 16.5 (199) , a period when yet been distinguished.
ovaries never express MIS (296) . Thus, if SF-1 is responsiThis assay developed for human SRY and the MIS ble for regulation of the MIS promoter in vivo, additional promoter (168) along with assays developed for SRY and tissue and sex-specific factors, possibly including the the fra-1 promoter (64) and for mouse Sry and reporters SF-1 hormone binding domain ligand, must preclude containing the consensus binding element (103) are the SF-1 from acting at this time. Homozygous disruption of first assays available to test function of the SRY mole-the SF-1 gene in mice leads to a phenotype where gonad cules. We have used our assay to demonstrate that SRY and adrenal development fails before the stage of MIS mutations associated with sex reversal in humans demon-transcription (257), so this knock-out cannot help deterstrate defects in transcription activity of the MIS promoter mine whether SF-1 is involved in MIS transcription in vivo. (see Figs. 2 and 6 ).
An alternative hypothesis to explain these findings is that additional factors can bind at the MIS-RE-1/M2 site to cause MIS transcription.
F. Additional Factors Involved in Regulation
The M2/MIS-RE-1 sequence containing the binding of the MIS Promoter site for SF-1 (6 bp) is part of a larger region of evolutionary conservation across species (12 bp), and when the entire Recent cloning of the mouse (296), rat (166), and 12-base element is used for gel-shift experiments using chicken (111) MIS genes, along with promoter sequencing testicular or ovarian nuclear extracts, the pattern of speupstream of the human and bovine genes (54, 55, 157) , cific DNA-binding activities detected is complex. In addinow permits precise studies of the regulation of MIS ex-tion to three male specific bands of distinct migration, pression in efforts to define transcription factors whose female-specific ovarian gel shifts are present concomitant activity may work with SRY or downstream of it in the with ovarian MIS expression (Fig. 7A) . We believe these pathway leading to male sexual differentiation. The 5-gel shifts are due to the granulosa cell compartment, since region upstream of MIS is notable for its close proximity they were detected in nuclear extract from a clinical granto the transcription unit for a spliceosome-associated pro-ulosa cell tumor specimen (Haqq et al., unpublished data). tein (SAP62), which is transcribed with the same orienta-Our laboratory is in the process of purifying an Ç20 kDa tion as the MIS gene (100). In mouse, SAP62 transcripts M2-DNA binding activity (Fig. 7B ) distinct in molecular use a polyadenylation signal at 0424 relative to the MIS weight compared with 51-kDa SF-1 from newborn bovine ATG start codon; in humans, SAP62 terminates at 0789. testes. This M2 binding protein might modify SF-1's tranUse of an approximately 0300 mouse MIS promoter frag-scription activity, or might exert its transcription influment to drive lacZ expression in transgenic mice is suffi-ence independent from SF-1. It is equally important, howcient to correctly initiate MIS expression in males at the ever, to rule out that this NH 2 -terminally blocked band same time the endogenous gene becomes active, embry-(Haqq et al., unpublished data) is not merely an enzymatically induced fragment of SF-1. onic day 12 in mice (162). However, these MIS promoter- A: electrophoretic mobility shift assay of nuclear extract prepared by microdissection of tissues labeled above gel lanes at indicated times during rat embryogenesis, performed by standard protocol (128) in 5% 38:2 acrylamidebis-acrylamide low cross-linking gels. Nuclear protein extract (10 mg), quantitated by the Bradford-Lowry assay, was used in each lane; probe was rat M2 5-CAggCACTgTCCCCAAggTCACC annealed to its 32 P-labeled complement. Control gel shifts were performed using a probe for ubiquitous protein H2TF1 (14a) and showed a robust H2TF1 gel shift in all cases, confirming integrity of all extracts. B: purification of a protein of Ç22 kDa binding to M2 MIS promoter DNA element. Nuclear extracts were prepared from newborn bovine testes by modification of an established procedure (89) making nuclei in a Waring blender. Crude nuclear extract was fractionated on heparin-agarose and subsequently salt eluted, dialyzed, and subjected to 2 rounds of purification on a DNA affinity column (223) made of a support matrix bound to multimerized M2 DNA sites. Coomassie-stained 15% SDS-PAGE of affinity-purified M2 DNA binding protein (5, 10, and 25 ml) were compared with known quantities (10, 20, and 100 pmol) of the 85-amino acid SRY HMG box expressed in Escherichia coli.
VII. SRY TRANSCRIPTION UNIT: WHAT
SRY start sites using mRNA in tissues in which SRY is normally expressed reveals start sites at 091 and 0501 REGULATES SRY EXPRESSION? (63) . The discrepancy between start sites found in transfection experiments compared with endogenous RNA Full-length copies of SRY have been obtained from mouse, human (372), rabbit (445), bovine (79), and rat from tissue sources suggests that tissue-or species-specific factors may be involved in transcription at the SRY (Haqq et al., unpublished data) species. In addition, partial clones of SRY from many other species have been ob-locus. tained by PCR amplification of their HMG DNA binding domains (72, 124). Several notable species-specific differ-VIII. AUTOSOMAL AND X-LINKED GENES ences exist in the organization of the SRY locus, the struc-INVOLVED IN SEX DETERMINATION ture of the gene itself, and the function of the expressed AND DIFFERENTIATION protein in transgenic mice and in biochemical assays. The putative promoter region of the SRY gene contains multiple potential SP1 binding sites, as well as possible autoregFinding that Sry as a transgene can make XX female mice develop as males indicates that most if not all downulatory binding sites for SRY itself. However, the human SRY promoter lacks a TATA box, which is present in all stream genes in the sex determination pathway are autosomal. Two autosomal gene products, testosterone and other species. Transcription start sites have been mapped for human SRY by two groups. One group expressed hu-MIS, are well-characterized modulators of the sexual phenotype and are discussed in separate sections below. man SRY in a mouse cell line finding two different start sites for SRY transcription at 0137 and 078 nucleotides DAX-1, an orphan member of the steroid hormone transcription factor family related to steroidogenic factor upstream of the ATG (384). In contrast, mapping human 1, is responsible for adrenal hypoplasia congenita (297, a Sertoli cell protein (32). It was purified to homogeneity (38, 39, 331), and both bovine and human MIS genes were 459). In patients with adrenal hypoplasia congenita, hypogonadotrophic hypogonadism results from the defect in cloned (54, 332) . Mü llerian inhibiting substance is one protein of a large superfamily whose members play key pituitary-gonadal-adrenal endocrine axis. DAX-1 maps to the same region of the X chromosome that is associated roles in development, wound healing, suppression of tumor growth, and feedback control of the pituitary-gonadal with male to female sex reversal when it is duplicated (26, 308, 360, 381); other duplications of Xp that do not hormone axis. Related proteins include transforming growth factor-b (84), nodal (461a), activins (190, 250 , 277, give rise to sex reversal were used to limit the critical interval to Xp21.3- 22.11 (16, 241, 299) . The sex reversal 411), inhibin (265), decapentaplegic and related molecules (90, 315), Vg-1 and related molecules (214, 359, 437) , osfunction is named dosage-sensitive sex reversal (DSS) (297) , and it is possible that DSS and DAX-1 are identical. teogenic proteins (313, 314) , bone morphogenesis factors (452) , cartilage-derived morphogenetic proteins (59), and However, other genes are present in the critical region of Xp21, so further experiments are needed to address the growth/differentiation factors (189, 247, 277, 281). Expression studies of MIS revealed synthesis of MIS not only in timing and tissue specificity of DAX-1 expression, whether the gene is subject to X-inactivation, and whether dupli-fetal and neonatal males, but also in females, where MIS is first synthesized in postnatal ovarian granulosa cells cated DAX-1 in transgenic animals gives the same phenotype as DSS. It will clarify matters greatly if molecular that surround and nourish developing oocytes, and then produced in dynamic fashion with rising levels throughout target genes downstream of DAX-1 are identified. Masafumi and Jameson (264) recently discovered a direct inter-the follicular phase, peaking just before ovulation, throughout female reproductive life (28, 296, 386, 409) . action between DAX-1 and SF-1 which resulted in inhibition of expression of SF-1 heterologous and homologous Mü llerian inhibiting substance is an inhibitor for several processes, including oocyte meiosis (387, 408) , the proreporter constructs.
duction of aromatase in the fetal ovary (86, 423) , and levels of aromatase and lutenizing hormone receptor in A. MIS and Sex Differentiation the postnatal ovary (87), and MIS blocks epidermal growth factor-induced synthesis of progesterone in postnatal granulosa cells (227) , suggesting that it plays a role Every normal person, XX or XY, has the potential to develop both male and female reproductive structures. in the control of granulosa cell steroidogenesis.
Cloning of MIS with subsequent investigations has During fetal life either the Wolffian or the Mü llerian duct must develop while the other must regress in response to confirmed Jost's foresight and enabled novel observations of MIS activities that suggest additional roles. Overexdifferentiation of bipotential gonads into either testes or ovaries. Professor Alfred Jost, in the late 1940s, first dis-pression of MIS in transgenic female mice resulted in a phenotype characterized by regression of Mü llerian ducts covered that the influence of the testis on male development required two hormones (219) . Jost surgically re-as predicted by Jost's experiments (20). However, the ovaries of these female mice exposed to supraphysiological moved the gonads of fetal rabbits during various stages of sexual differentiation. Removal of either testes or ovaries levels of MIS became depleted of germ cells and formed structures reminiscent of seminiferous tubules. Mutation before, or at the outset of gonadal differentiation, resulted in female somatic development, the Wolffian ducts re-of the MIS gene is associated with the persistent Mü llerian duct syndrome (52, 200, 233) . Surprisingly, many of these gressed instead of going on to form the vas deferens and seminiferous tubules, while the Mü llerian ducts persisted mutations are located in the NH 2 terminal of MIS, whose role in bioactivity is not fully understood (447). Enzymeand developed into the oviducts, uterus, and upper vagina. When Jost transplanted a testis into a female fetus, Mü lle-linked immunosorbent assay detection of mutant protein levels are lower than wild type, perhaps indicating that rian ducts were inhibited and Wolffian ducts persisted. The converse transplant of ovary to male had no effect. these mutations affect translatability or stability of the protein; however, the same result would hold if the mutaFinally, when a crystal of synthetic androgen, instead of an entire testis, was placed in the abdomen of a castrated tions interfered with recognition by the antisera, so further work will be required to show the precise molecular male, Wolffian development was supported but the Mü llerian system failed to regress. Therefore, Jost (219, 220) mechanism for these mutations leading to the persistent Mü llerian duct syndrome. postulated the existence of two hormones, one an androgen that would support male Wolffian duct development One-fourth of male mice exposed to supraphysiological levels of human MIS showed feminized testes and exand a second called l'hormone inhibitrice or the Mü llerian inhibitor, responsible for regression of developing female ternal genitalia (20). Thus MIS may play a role in the formation of gonadal and external genital structure, per-Mü llerian structures.
L'hormone inhibitrice, later called MIS (217) that MIS decreases levels of disaturated phosphatidlycho-inhibin were constructed. a-Inhibin-deficient mice develop focal Sertoli/granulosa cell tumors (271). Doubleline, the major component of surfactant in fetal lungs, which led to the hypothesis that MIS may contribute to deficient mice lacking both MIS and a-inhibin show multifocal Leydig cell hyperplasia as well as multifocal the male preponderance in newborn infants of respiratory distress syndrome. Finally, the role of MIS as a negative Sertoli/granulosa tumors occurring at a much earlier age than with single gene deficiencies (270) , confirming the growth regulator in fetal life suggested that MIS might have antitumor activity against neoplastic cells, especially role of these molecules as tumor suppressors in vivo and showing their synergy with combined deficiency. These those derived from Mü llerian duct structures. These effects were apparent for ovarian and uterine carcinoma results point to MIS and related molecules as targets for anticancer drug development. It will be interesting to see cell lines (61, 98) and primary tumors (133) . In whole animal experiments conducted in nude mice, recombinant the result of doubly deficient mice for MIS and the related oocyte-specific molecule GDF-9 (277). human MIS had potent inhibitory activity against the growth and reduced the number of metastases of an ocular melanoma (323).
B. Mutation of the MIS Type II Receptor and MIS Homozygous deletion of the MIS gene resulted
Receptor Signal Transduction in male mice with retained Mü llerian ducts. Female MIS 0/0 mice were fully fertile, whereas most males were
Results consistent with the identification of the MIS infertile due to anatomic blockage of sperm egress; in type II receptor (13, 87, 88, 396, 426) come from identifivitro fertilization with their sperm resulted in production cation of a receptor mutation that leads to the persistent of normal offspring (20). Newborn males showed no respi-Mü llerian duct syndrome. Mutation of the 5-splice donor ratory distress or developmental lung defects (20). These site for intron 2 led to aberrant splicing of the gene prodfindings are surprising given the tightly regulated expres-uct in mRNA prepared from a biopsy of testicular tissue sion of MIS in the ovary and its proposed roles as a control (201). Confirmation of the developmental role of this type factor for granulosa cell steroid production and oocyte II receptor was proven by the homozygous knock-out of meiosis, for architectural differentiation of the testes and the mouse receptor, which showed the phenotypes of remale external genitalia, and for lung surfactant synthesis. tained Mü llerian ducts, almost identical to that caused by To explain this enigma, it has been proposed that genes the ligand knock-out (289). related to MIS may be present in Sertoli and granulosa
The family of transforming growth factor-b receptors cells and may be redundant for certain MIS functions, or is thought to function by the type II receptor first binding that certain functions of MIS are species specific (20). ligand, which then gives the type II receptor competence Because MIS is known to inhibit P-450 aromatase and to dimerize with, or recruit, the type I receptor, which in because a subset of mammals express P-450 aromatase turn is responsible for signal transduction. The intracelluin the placenta, one may speculate that MIS phenotypes lar domain of the putative type I MIS receptor candidate with regard to effects on steroidogenesis will be found to has been used as the bait in yeast interaction trap experibe species specific on the basis of placental expression ments that identified one of its intracellular interactors to of aromatase activity. Mice deficient for MIS had a high be FKBP12, the binding substrate for the widely used incidence (27%) of Leydig cell hyperplasia on histological immunosuppressant drugs FK506 and cyclosporin (433, examination, and one animal produced a Leydig cell neo-434). Subsequent studies have shown that FKBP12 is replasm, suggesting a role for MIS as a tumor suppressor leased from the type I receptors upon ligand binding, gene. A putative heterodimer receptor for MIS, consisting which implies that FKBP12 acts as an inhibitor of signal of two transmembrane serine/threonine kinases, type I transduction (434). We have identified other specific cyto-(178) and type II (13, 88, 396, 426) , has been isolated. solic interactors with the MIS type I receptor (Wang et Mutation of this type II receptor, like mutation of MIS al., unpublished data) that are being characterized as poitself, is associated with persistent Mü llerian duct syn-tential positive regulators for the MIS-induced signal drome (201), and MIS type II receptor expression ap-transduction cascade. peared to be limited to Sertoli cells and mesenchymal cells surrounding the Mü llerian duct in males (396) . However, because Leydig cells have no MIS receptor, but experience C. Role of Androgens and Sex Steroids in Sex Differentiation effects of MIS as a Leydig cell tumor suppressor, localization of MIS receptors on Leydig cells deserves further study.
Normal androgen action is essential for male anatomic sex differentiation and reproductive function. HeTo address the question of whether redundancy of a related molecule might be masking some expected pheno-reditary defects that diminish androgen action in chromosomal males or that increase androgen action in chromotypes of the homozygous MIS-deficient mice, mice doubly deficient in both MIS and the related Sertoli cell product somal female patients result in the most frequently by 10.220.33.4 on September 27, 2017 http://physrev.physiology.org/ Downloaded from diagnosed disorders of sexual differentiation (reviewed Defects in P-450 aromatase render patients unable to convert precursors to the female sex steroids estradiol, in Refs. 93, 154). Leydig cells, induced to differentiate by SRY-expressing fetal Sertoli cells, are an essential site estrone, and estriol. Only a handful of patients have been described with this syndrome of female pseudohermaphof testosterone biosynthesis during male differentiation. Testosterone is synthesized from cholesterol through the roditism. However, a partial deficiency seems to be more common and may account for some fraction of women activities of side chain cleavage, 3b-and 17b-dehydrogenation (P-450scc, P-450c17; 3B-HSD and 17B-HSD; re-with polycystic ovaries due to hypergonadotropic stimulation in the absence of estrogen to cause negative feedback viewed in Ref. 288) .
at the hypothalamus (69). More marked effects of aromatase deficiency during fetal life may be masked by D. Defects in Steroid Biosynthesis Lead maternal expression of placental aromatase, resulting in to an Intersex Phenotype and Congenital sufficient female sex steroids during fetal life.
Adrenal Hyperplasia
A defect in regulation of the steroidogenic genes, rather than mutations of the enzymes themselves, is likely Defects in testosterone biosynthesis result in a phenotype with a male gonad but incompletely masculinized to cause additional defects in steroid biosynthesis. Several steroidogenic genes are known to be regulated by SF-1 Wolffian duct structures and/or external genitalia, termed male pseudohermaphroditism. Female pseudohermaph-(also called ADBP4), a member of the steroid hormone receptor family of transcription factors that binds DNA roditism may occur when defects in enzymes leading to glucocorticoids and mineralocorticoids are present, lead-as a monomer (186, 198) . SF-1 is an orphan receptor, since the ligand that binds its hormone binding domain has not ing to shunting of precursor molecules into the androgenic pathway, or when defects in estrogen formation are yet been identified. SF-1 binds to a common DNA sequence present in the promoters of P-450scc, P-450c11, present. The defects in steroid biosynthesis, their clinical diagnosis, and management have been recently reviewed P-450c21, P-450c17 and P-450 aromatase (259, 294). However, P-450c11 and P-450c21 are expressed in adrenals (93) . CYP21 21-hydroxylase deficiency has the greatest clinical significance, accounting for ú90% of steroid bio-but not gonads, whereas P-450 aromatase is expressed in gonads and not adrenals despite the fact that SF-1 is synthetic defects, with an incidence between 1:10,000 and 1:18,000 live births (93) . Mutation of CYP21 results in the expressed in both organs (199) . This suggests there are as yet unidentified factors limiting tissue-specific expresclinical syndrome of congenital adrenal hyperplasia, a form of female pseudohermaphroditism due to insuffi-sion or activation of these genes (305). cient mineralocorticoid and precursor shunting into the androgenic pathway. Because the CYP21 gene and a pseu-E. Defects in the Androgen Receptor Lead dogene CYP21P lie together in close proximity, unequal to Testicular Feminization crossing over and gene conversion events in addition to point mutations are the molecular basis of 21-hydroxylase deficiency (for example, Ref.
92). CYP11B1 11b-hydroxy-
The two predominant androgens in humans, testosterone and dihydrotestosterone, both bind the same relase deficiency is the next most common cause, resulting in 5% of cases (for example, Ref. by the hypothalamic-pituitary axis, and spermatogenesis. been described at the molecular level (93) .
Mutations in 3b-hydroxysteroid dehydrogenase (3b-The receptor-dihydrotestosterone complex promotes development of the external genitalia and prostate during HSD) are also a rare cause of insufficient masculinization; in females, the phenotype is actually related to the mild embryogenesis and also is responsible for pubertal changes including growth of the adult hair pattern, tempoandrogen excess caused by peripheral conversion of dehydroepiandosterone, one of the substrates for 3b-HSD ac-ral hair recession, and maturation of the external genitalia and has been suggested to regulate male-specific behavtivity (371). Three genes encoding constitutive, placental, and testes-specific 17b-HSD activity, respectively, have ior. The reason for distinct responses to the two hormones binding the same receptor may be due to difference in been isolated (136, 326, 397, 453) . Of the three isozymes, only the type 3 testicular isozyme is responsible for the binding affinity (dihydrotestosterone has higher affinity for the androgen receptor) or a qualitative effect on recepbulk of clinical 17b-HSD deficiency (136) . It is not clear why these patients virilize at puberty. Either there may tor function (receptor-dihydrotestosterone is able to activate reporter gene constructs more easily; reviewed in be sufficient type I and type II activity to produce adequate testosterone in response to pubertal hypophysial signals, Ref. 154). The androgen receptor, a member of the steroid receptor superfamily, is an X-linked locus in humans or an as yet undiscovered isozyme present only post puberty might exist.
whose complete deficiency leads to the syndrome of tes- 306) . A third possibility to explain XX maleness ticular feminization, or complete androgen insensitivity is mutation in autosomal or X-linked (394) genes distinct (58, 256, 400) . Patients with testicular feminization tend from SOX 9, DAX-1, MIS, and androgen receptors, leading to be taller than average women, and tooth size is as large to a constitutive activation of a male determining gene or as normal men (6, 417), as can be explained by the fact loss of function in a female-determining gene. Evidence that they have Y chromosomal genes described above.
for loss of function of just such an ovary-determining gene Some mutations in the androgen receptor do not comhas been found in studies of familial ovarian dysgenesis pletely inactivate the receptor and thus lead to deficient (421) . but not completely absent masculinization. Patients with
In humans, several syndromic conditions are associReifenstein syndrome (280) show the phenotype of these ated with abnormal sexual differentiation of XY individudefects. A rare class of testicular feminization patients als; most of these involve sex reversal of XY infants to may result from Leydig cell agenesis or hypoplasia that a female phenotype. They include campomelic dysplasia has been seen in cases consistent with autosomal reces-(discussed in sect. VIA; SOX 9), Smith-Lemli-Opitz (30), sive and dosage sensitive Y-linked inheritance (137, 354) .
Denys-Drash (324), and X-linked a-thalassemia/mental retardation syndrome (140) . Also, ambiguous genitalia are F. Defects in Steroid 5a-Reductase Result in an seen when patients are monosomic for autosomal loci on Intersex Phenotype chromosome 9 (22, 78, 130, 187, 252) . It should be noted that one sex-determining autosomal locus on mouse chroPatients with female external genitalia at birth, bilat-mosome 4 (108) is syntenic with this region of human eral testes, and normally virilized Wolffian structures that chromosome 9, suggesting the two loci may encode hoterminate at the vagina frequently have steroid 5a-reduc-mologous gene products. A case report showed that deletase deficiency resulting in an inability to form dihydrotes-tion of 10q (446) was associated with an intersex phenotosterone (202, 431). Of the two known isoforms of this type that included cryptorchidism, micropenis, and hypoenzyme, the type II enzyme is present in the external spadias. In addition, there are several reports of genitalia, where dihydrotestosterone is the dominant an-autosomal recessive inheritance of gonadal agenesis (82, drogen required to elongate and ventrally close the penile 85, 284, 356) or gonadal dysgenesis (218, 312, 349) . Cases anlagen translocating the urethral meatus from the peri-of agonadism lack the virilization and complete or partial neum to the tip of the penis. Cloning of the chromosome involution of the Mü llerian system seen with gonadal dys-19 gene for steroid 5a-reductase 2 has permitted identifi-genesis, which results from active testicular tissue before cation of mutations of this gene in 36 of 37 families with degeneration and disappearance. In some cases, gonadal clinical features of the disorder (7, 398); the one family dysgenesis is associated with additional congenital malwhere no mutations were found within the exons is formations including midline defects (226, 337a) . A few thought to have suffered a genetic insult in a noncoding reports describe families with inheritance consistent with region, resulting in diminished expression of the gene an X-linked form of partial gonadal dysgenesis (see Ref.
product. Reductase deficiency disorder is so common in 114 for review); because the gonadal phenotypes seen in certain inbred groups that children with ambiguous geni-these families are largely disparate, it is possible that more talia are not raised as male or female, but instead are than one X-linked locus could be responsible for this given a third sex assignment in a New Guinea highland group of patients. tribe (154).
There are several animal models for such conditions (105, 106, 164, 375) . Seven dog breeds are known to exhibit XX sex reversal (286, 287), which might be due to G. Additional Autosomal Genes Involved SRY translocation to another chromosome or to mutain Sex Differentiation tions in an autosome. Meyers-Wallen and co-workers (286, 287) have shown that two of these dog breeds lack SRY In XX sex reversal, first recognized by de la Chapelle sequences, and thus an autosomal mutation must be reet al. many years that the Y chromosome from Old World wild is preserved in ovotestes, it is unlikely that a delay in Sry ontogeny is the only factor leading to sex reversal in this mice (Mus domesticus) bred into the B6 inbred lab strain derived from the house mouse (Mus musculus) causes a model, although levels of Sry protein have not yet been correlated with transcript levels. Future work will seek high incidence of XY female progeny. When studied during embryogenesis, these embryos start out with bilateral to understand what is different about M. domesticus that results in its defective function. Is the defect in the Sry ovotestes, but the testicular elements regress over time so that the adult phenotype is a sterile XY female. Some gene itself, in regulatory regions surrounding Sry on the Y chromosome or even in some part of the Y chromosome, breeding experiments produce a delay in the timing of seminiferous tubule formation by Ç14 h (320, 389) , which unrelated to the Sry locus?
One hypothesis is that Sry molecules from these corresponds to a delay in Sertoli cell differentiation as detected by the production of MIS, assayed by immunohis-strains have different structures. There is some evidence to support this; several strains have Sry molecules that tochemisty or RT-PCR, in these gonads (245, 309). The interpretation is that the M. domesticus fails to interact have a premature stop codon relative to the 129 mouse strain in which Sry was first characterized. Being shorter properly with autosomal genes in the house mouse, either because of a lag in Sry expression to a period where is not thought to result in sex reversal, however, since Y chromosomes of several strains, FVB/N, SJL, and SWR/J, ovary-determining signals take effect or, because of a qualitative defect in the Sry protein, to initiate normal which have the premature stop codon do not cause sex reversal (75, 107 ). An additional difference in Sry moledevelopment. To address this question, Lee and Taketo (245) used RT-PCR to study Sry expression in ovotestes, cules detected by Coward et al. (75) was the length of a trinucleotide repeat polymorphism present COOH termifinding that onset of Sry transcription is unperturbed but that the duration of SRY expression is prolonged by ú24 nal to the HMG domain. At first the number of CAG repeats appeared correlated with the function of the Sry h, which they suggest leads to upregulation of gene transcription by a feedback mechanism due to a poor re-molecules, but exceptions have been found (107) phisms reflect an additional allelic difference specific to advance in understanding sexual differentiation, providparticular mouse strains, possibly including mutations in ing insight into two types of human intersex patients, 46, the Sry promoter regulatory region. Formal testing of XY women and 46, XX true hermaphrodites. Because whether it is a defective Sry or some other Y-linked locus many human mutations resulting in intersex abnormalithat is responsible for the development of ovotestes ties are compatible with life, the large clinical literature awaits experiments with transgenic mice where one Sry available makes detailed investigations possible. Many molecule can be swapped for another while keeping the model systems are now available in mammals that promrest of the Y chromosome and autosomes the same.
ise to permit characterization of SRY, related SOX genes, Sry has been suggested to repress a gene that func-and other molecules of the regulatory cascade necessary tions in the absence of the Y chromosome to initiate ovar-to form a testis. Insight into genes that control ovarian ian development (276) , and efforts are underway to clone development is beginning to solidify around dosage-sensithe autosomal loci that interact with Y chromosomes in tive sex reversal associated with the X chromosome and a strain-specific fashion. It will be interesting to see if study of the Turner syndrome phenotype. It is gratifying autosomal genes cloned by this approach fulfill this pre-to know that experiments are currently underway that in diction, and how they play their roles in the sex determina-time could systematically elucidate the entire program by tion and testicular differentiation cascade.
which chromosomal sex is translated into phenotypic sex. We hope that, ultimately, intersex patients will be able to IX. TISSUE-SPECIFIC MARKERS OF benefit in their clinical care from these investigations.
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